These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4643 related items for PubMed ID: 6484793

  • 1. Sex related survival differences in instances of melanoma.
    Reintgen DS, Paull DE, Seigler HF, Cox EB, McCarty KS.
    Surg Gynecol Obstet; 1984 Oct; 159(4):367-72. PubMed ID: 6484793
    [Abstract] [Full Text] [Related]

  • 2. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C.
    Cancer; 2008 Apr 15; 112(8):1795-804. PubMed ID: 18306371
    [Abstract] [Full Text] [Related]

  • 3. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS.
    Cancer; 2000 Feb 01; 88(3):589-95. PubMed ID: 10649252
    [Abstract] [Full Text] [Related]

  • 4. Investigation of female survival benefit in metastatic melanoma.
    Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, Miller JG, Mac Neil S.
    Br J Cancer; 1999 Aug 01; 80(12):2025-33. PubMed ID: 10471056
    [Abstract] [Full Text] [Related]

  • 5. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Möller T, Sjödin H, Stierner U, Wagenius G, Swedish Melanoma Study Group.
    Cancer; 2004 Nov 01; 101(9):2067-78. PubMed ID: 15372475
    [Abstract] [Full Text] [Related]

  • 6. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V, Pekmezović T, Adanja B, Jarebinski M, Marinković J, Tomin R.
    Srp Arh Celok Lek; 1997 Nov 01; 125(5-6):132-7. PubMed ID: 9265233
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of prognostic factors in malignant melanoma according to the actuarial method: report of 75 cases (author's transl)].
    Pelletier N, Claudy A, Thivolet J.
    Dermatologica; 1978 Nov 01; 157(4):210-20. PubMed ID: 689232
    [Abstract] [Full Text] [Related]

  • 8. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS.
    Cancer; 1997 Oct 15; 80(8):1426-31. PubMed ID: 9338466
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy and early-stage melanoma.
    Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ.
    Cancer; 2003 May 01; 97(9):2248-53. PubMed ID: 12712479
    [Abstract] [Full Text] [Related]

  • 10. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr 01; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 11. Gender and survival in malignant tumours.
    Molife R, Lorigan P, MacNeil S.
    Cancer Treat Rev; 2001 Aug 01; 27(4):201-9. PubMed ID: 11545540
    [Abstract] [Full Text] [Related]

  • 12. Survival rates of patients with malignant melanoma of the skin.
    Pakkanen M.
    Ann Chir Gynaecol; 1977 Aug 01; 66(1):31-5. PubMed ID: 848849
    [Abstract] [Full Text] [Related]

  • 13. Prognosis of malignant melanoma.
    Rigel DS, Rogers GS, Friedman RJ.
    Dermatol Clin; 1985 Apr 01; 3(2):309-14. PubMed ID: 3830493
    [Abstract] [Full Text] [Related]

  • 14. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 01; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 15. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL, Fine JA, Roush GC, Berwick M.
    Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
    Palangié A, Lassau F, Moreau T, Noury-Duperrat G, Cottenot F.
    Nouv Presse Med; 1981 Jun 27; 10(28):2337-41. PubMed ID: 7267338
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cutaneous malignant melanoma in south-east Scotland.
    Pondes S, Hunter JA, White H, McIntyre MA, Prescott RJ.
    Q J Med; 1981 Jun 27; 50(197):103-21. PubMed ID: 7267966
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M.
    Cancer; 2002 Feb 15; 94(4):1049-56. PubMed ID: 11920475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 233.